India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

J B Chemicals & Pharmaceuticals Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	23744.56 Cr.	P/BV	7.39	Book Value (`)	206.25
52 Week High/Low ( ` )	2030/1386	FV/ML	1/1	P/E(X)	42.97
Book Closure	08/02/2025	EPS (`)	35.48	Div Yield (%)	0.80

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1551.95	773.78	772.82	772.82	772.82

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	15.52	15.48	15.46	15.46	15.46
Total Share Capital	15.52	15.48	15.46	15.46	15.46

Reserves and Surplus	2907.81	2343.26	2056.01	1794.27	1420.03
Total Reserves and Surplus	2907.81	2343.26	2056.01	1794.27	1420.03
Employees Stock Options	0.00	121.59	62.65	0.00	0.00
Total Shareholders Funds	2923.33	2480.33	2134.12	1809.72	1435.49
Equity Share Application Money	0.00	0.03	0.00	0.00	0.00
Minority Interest	0.00	0.00	4.49	3.71	2.50

NON-CURRENT LIABILITIES
Long Term Borrowings	23.64	383.22	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	149.21	102.82	47.56	56.77	48.14
Other Long Term Liabilities	11.34	17.81	23.78	10.07	7.20
Long Term Provisions	18.39	15.21	13.73	12.57	7.39
Total Non-Current Liabilities	202.57	519.07	85.07	79.41	62.72

CURRENT LIABILITIES
Short Term Borrowings	333.50	165.02	26.32	32.64	32.04
Trade Payables	356.31	238.65	224.48	186.92	123.79
Other Current Liabilities	129.35	108.28	87.40	97.73	149.90
Short Term Provisions	49.06	42.50	45.52	27.98	7.11
Total Current Liabilities	868.23	554.45	383.72	345.27	312.85

Total Capital And Liabilities	3994.13	3553.87	2607.40	2238.12	1813.56

ASSETS
NON-CURRENT ASSETS
Tangible Assets	571.56	532.01	552.91	544.09	568.03
Intangible Assets	1375.38	1311.54	666.63	32.11	30.09
Capital Work-In-Progress	63.32	44.41	13.91	25.57	16.17
Intangible Assets Under Development	13.08	10.74	4.77	0.00	0.00
Fixed Assets	2023.34	1898.70	1238.21	601.76	614.29
Goodwill On Consolidation	57.46	57.46	57.46	57.46	53.14
Non-Current Investments	23.71	13.78	12.72	12.91	69.45
Deferred Tax Assets [Net]	5.88	6.51	6.43	6.94	0.00
Long Term Loans And Advances	0.58	0.68	0.74	5.19	0.28
Other Non-Current Assets	29.82	48.70	16.98	1.25	3.67
Total Non-Current Assets	2140.78	2025.84	1332.55	685.51	740.83


CURRENT ASSETS
Current Investments	364.65	192.18	0.00	664.97	333.81
Inventories	502.51	430.48	409.96	347.45	274.67
Trade Receivables	686.92	575.80	555.69	389.02	345.43
Cash And Cash Equivalents	95.54	78.81	58.53	30.85	30.95
Short Term Loans And Advances	0.70	1.37	1.30	1.93	4.21
OtherCurrentAssets	203.03	249.38	249.38	118.38	83.66
Total Current Assets	1853.35	1528.03	1274.86	1552.60	1072.73

Total Assets	3994.13	3553.87	2607.40	2238.12	1813.56

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1110.90	148.86	68.13	121.03	121.66

BONUS DETAILS
Bonus Equity Share Capital	8.46	8.46	8.46	8.46	8.46

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	56.57
Non-Current Investments Unquoted Book Value	23.71	13.78	12.72	12.91	12.88

CURRENT INVESTMENTS
Current Investments Quoted Market Value	364.65	0.00	0.00	664.97	333.81

J B Chemicals & Pharmaceuticals Ltd.

Ratio Analysis - Consolidated

Market Cap.(`)	23744.56 Cr.	P/BV	7.39	Book Value (`)	206.25
52 Week High/Low ( ` )	2030/1386	FV/ML	1/1	P/E(X)	42.97
Book Closure	08/02/2025	EPS (`)	35.48	Div Yield (%)	0.80

You can view the Consolidated Ratio Analysis for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	2.00	2.00	2.00	2.00

PER SHARE RATIOS

Basic EPS (Rs.)	35.66	53.00	49.86	57.96	34.20
Diluted EPS (Rs.)	34.85	52.34	49.86	57.96	34.20
Cash EPS (Rs.)	44.52	67.77	59.35	66.92	43.83
Book Value[Excl.RevalReserv]/Share (Rs.)	188.36	320.55	276.73	234.65	186.07
Book Value[Incl.RevalReserv]/Share (Rs.)	188.36	320.55	276.73	234.65	186.07
Revenue From Operations / Share (Rs.)	224.50	407.00	313.69	264.29	229.64
PBDIT / Share (Rs.)	60.19	91.20	75.40	87.06	55.41
PBIT / Share (Rs.)	51.28	76.42	66.00	78.17	46.83
PBT / Share (Rs.)	48.42	71.76	65.33	77.23	45.15
Net Profit / Share (Rs.)	35.61	52.99	49.95	58.04	35.25
NP After MI And SOA / Share (Rs.)	35.61	52.97	49.86	57.96	35.20

PROFITABILITY RATIOS

PBDIT Margin (%)	26.81	22.40	24.03	32.93	24.13
PBIT Margin (%)	22.84	18.77	21.03	29.57	20.39
PBT Margin (%)	21.56	17.63	20.82	29.22	19.65
Net Profit Margin (%)	15.86	13.01	15.92	21.95	15.34
NP After MI And SOA Margin (%)	15.86	13.01	15.89	21.93	15.32
Return on Networth / Equity (%)	18.90	16.52	18.05	24.75	18.95
Return on Capital Employeed (%)	25.45	19.71	22.93	31.91	24.11
Return On Assets (%)	13.83	11.53	14.77	20.01	15.00
Long Term Debt / Equity (X)	0.01	0.15	0.00	0.00	0.00
Total Debt / Equity (X)	0.12	0.22	0.01	0.01	0.02
Asset Turnover Ratio (%)	0.92	1.02	0.91	0.94	0.91

LIQUIDITY RATIOS

Current Ratio (X)	2.13	2.76	3.32	4.50	3.43
Quick Ratio (X)	1.56	1.98	2.25	3.49	2.55
Inventory Turnover Ratio (X)	1.75	1.87	1.73	1.96	1.90
Dividend Payout Ratio (NP) (%)	28.40	31.13	33.09	16.38	52.02
Dividend Payout Ratio (CP) (%)	22.72	24.33	27.84	14.21	41.82
Earning Retention Ratio (%)	71.60	68.87	66.91	83.62	47.98
Cash Earning Retention Ratio (%)	77.28	75.67	72.16	85.79	58.18

COVERAGE RATIOS

Interest Coverage Ratio (%)	21.07	19.57	113.79	92.91	141.35
Interest Coverage Ratio (Post Tax) (%)	13.47	12.37	76.39	62.94	94.21

VALUATION RATIOS

Enterprise Value (Cr.)	25860.24	15719.76	12145.74	9693.57	3932.22
EV / Net Operating Revenue (X)	7.42	4.99	5.01	4.75	2.22
EV / EBITDA (X)	27.68	22.28	20.84	14.41	9.18
MarketCap / Net Operating Revenue (X)	7.35	4.84	5.02	4.74	2.21
Retention Ratios (%)	71.59	68.86	66.90	83.61	47.97
Price / BV (X)	8.76	6.15	5.70	5.35	2.74
Price / Net Operating Revenue (X)	7.35	4.84	5.02	4.74	2.21
EarningsYield	0.02	0.02	0.03	0.04	0.06

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

J B Chemicals & Pharmaceuticals Ltd.

Balance Sheet - Consolidated

J B Chemicals & Pharmaceuticals Ltd.

Ratio Analysis - Consolidated